Psycho-Social Outcomes Following Emergency Laparotomy (POLO)

An emergency laparotomy (EmLap) is a life-saving operation; but the aftermath for those that do survive can be lifechanging. Each year, in excess of 25,000 EmLaps are performed in UK. A national effort, through the National Emergency Laparotomy Audit (NELA), has managed to improve peri-operative care, and reduce 30 day mortality from 1 in 4 to less than 1 in 10. Whilst this reduction should be commended, it also means that more patients are surviving with some form of new infirmity.

This infirmity may be short-lived and reversible in some, and yet others may transition into a permanent chronic disease state. The impact of EmLap on those individuals that "do not fully recover" is far-reaching and often interlinked, covering biological, social and psychological domains. This makes it difficult to describe the true problem, i.e. holistic morbidity and suggest an intervention to improve it.

The primary aim of this work is to describe the holistic morbidity of EmLap throughout the first year of a patient's recovery.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

175

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cardiff, United Kingdom, CF14 4XW
        • Julie Cornish
    • Renfrewshire
      • Paisley, Renfrewshire, United Kingdom, PA2 9PJ
        • Royal Alexandra Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study population is all patients who have undergone emergency laparotomy during their admission to hospital, are recovering well and approaching discharge. Participants will be recruited from hospital sites in Wales and Scotland.

Description

Inclusion Criteria:

  • 18 years or above
  • Able to communicate in English
  • Cognitively able to complete the questionnaire
  • Able to provide informed voluntary consent
  • Undergone an EmLap during admission
  • Clinical team anticipate to be "medically fit for discharge" within 48 hours (of consent)

Exclusion Criteria:

  • Any terminal diagnosis in which the clinical team do not anticipate life expectancy to exceed 6 months from the time of surgery
  • Acutely unwell at the time of recruitment. These patients may still be eligible and can be re-screened and recruited at a later date, should their condition improve.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Emergency Laparotomy Patients
All adult patients (18+) who have undergone Emergency Laparotomy surgery, are recovering well (no illness which is expected to limit life to <6m post op) and have sufficient English-language and cognitive skills to complete the study questionnaires.
All patients undergoing Emergency Laparotomy
Family Caregivers
Adult (18+) family members, close friend or caregivers of the individual who has received EmLap treatment have sufficient English-language and cognitive skills to complete the study questionnaires.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change in patient reported Quality of Life as assessed by the EuroQuol 5-Dimension Health-related Quality of Life instrument (EQ-5D)
Time Frame: 12 months
Patient reported Quality of Life will be measured at 3 time points post-discharge. Reduction of EQ-5D 3-Level scale (min.5; max 15) and EQ-5D Visual Analogue Scale (min 0; max. 100) represent improved quality of life.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Establishing the patient definition of 'Recovery' following Emergency Laparotomy using qualitative methods
Time Frame: 12 months

Semi-structured qualitative interviews will be conducted with approximately 15 Emergency Laparotomy patients, at 6-months post-discharge from hospital. The interview will evaluate:

A) what patients consider to constitute 'recovery' following emergency laparotomy B) what factors influence achieving 'recovery' C) the timelines linked to a) and b)

12 months
Change in Fatigue Severity Score
Time Frame: 12 months
Fatigue severity score (FSS) to assess physical health. Measured at 3 time-points post-operatively and scored from 9 (min.) to 63 (max.), with increase in total score represents greater fatigue severity/ reduced physical health.
12 months
Change in Body Mass Index
Time Frame: 12 months
Body Mass Index (BMI) to assess physical health. Weight and Height will be recorded in kg and cm (respectively) at 3 time-points and BMI will be calculated and reported in terms of kg/m^2.
12 months
Change in Rockwood Frailty Score
Time Frame: 12 months
Rockwood Frailty Score to asses physical health. Collected at 3 time-points and scored from 1 (min.) to 9 (max.), where greater score represents increased frailty. Only validated for use in the over 65's
12 months
Change in Gastro-Intestinal Quality of Life Index
Time Frame: 12 months
Gastro-intestinal Quality of Life Index (GIQLI) to assess in physical health. Collected at 3 time-points, total score calculated from 0 (min.) to 144 ( max.), where greater total score represents improved GI health related QoL.
12 months
Change in International Trauma Questionnaire score
Time Frame: 12 months
International Trauma Questionnaire to assess mental-health. Collected at 3 timepoints. Scored in accordance with assessment guidance to determine clinical signs of (complex) Post-Traumatic Stress Disorder.
12 months
Change in Patient Health Questionnaire score
Time Frame: 12 months
Patient Health Questionnaire (PHQ9) to assess mental-health. Collected at 3 timepoints and scored from 0 (min.) to 27 (max.), where greater score represents increased depression severity.
12 months
Change in Generalised Anxiety Disorder assessment score
Time Frame: 12 months
Generalised Anxiety Disorder assessment (GAD7) to assess mental-health. Measured at 3 timepoints from 0 (min.) to 21 (max.), where greater score represents increased anxiety severity.
12 months
Changes in Community Integration Questionnaire score
Time Frame: 12 months
Community Integration Questionnaire (CIQ) to determine changes in social integration. Scored between 0 (min.) and 35 (max.), where greater score represents reduced social integration.
12 months
Change in sexual function
Time Frame: 12 months
Single question regarding change in sexual function (min 0; max 5), where greater score represents increased sexual impairment
12 months
Change in employment status
Time Frame: 12 months
Single question regarding change in employment status (yes/no).
12 months
The changes in care burden as assessed by the Modified Caregiver Strain Index (MCSI)
Time Frame: 12 months
Caregiver- reported burden will be measured at 3 timepoints post-discharge. Increase in total score of the Modified Caregiver Strain Index (MCSI) (min. 0; max. 26), represents greater burden on caregiver.
12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall patient experience of Emergency Laparotomy care as assessed by the NHS Wales Experience Questionnaire
Time Frame: 12 months
Patient experience will be assessed at a 3 time-points during the course of their recovery at the end of the study using the NHS Wales Patient Experience questionnaire. Overall experience is measured on 10-point Likert scale (0-least satisfied, 10 most satisfied).
12 months
Number of patient points of care
Time Frame: 12 months
Incidence of scheduled and unscheduled care will be measured over the course of the patients involvement in the project
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 15, 2021

Primary Completion (Estimated)

September 30, 2023

Study Completion (Estimated)

September 30, 2024

Study Registration Dates

First Submitted

November 29, 2021

First Submitted That Met QC Criteria

March 11, 2022

First Posted (Actual)

March 16, 2022

Study Record Updates

Last Update Posted (Actual)

July 20, 2023

Last Update Submitted That Met QC Criteria

July 19, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 8160

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emergency Laparotomy

Clinical Trials on Emergency Laparotomy

3
Subscribe